Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

BlueNotes

Biotechnology in water and Industrial stormwater

11 Jan 2018

Description

Over the last few years, our ability to make sense of biological information has increased in sophistication. Today, we can predict the 3-dimensional structure of an enzyme, simulate activity and optimize the molecule using computational biotechnology tools. The cost of biological information/data has also dramatically declined. In the podcast we speak with Jens Kolind from Novozymes on what all this means for water going forward and the challenges in implementing biotechnology on a wider scale in water treatment. We also focus in on industrial Stormwater and speak to Ryan Janoch from Mapistry. The interest in this area is fast growing at both a public and company level. For a company, industrial stormwater presents both an environmental and financial risk. The Clean Water Federation Act offers an opportunity for citizens to file a complaint against non-compliant companies on behalf of public and regulatory agencies. The rate of lawsuits filed against organizations in California has increased to 30 a month and it is likely this will occur in other parts of the United States. This litigation aspect will likely tighten stormwater permits across the country in the coming years. --Presented by BlueTech Research®, Actionable Water Technology Market Intelligence. Watch the trailer of Our Blue World: A Water Odyssey. Get involved, and learn more on the website: braveblue.world

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.